• Pfizer appointed Cecile Guegan chief financial officer and executive vice president, effective November 1, 2026.
• Guegan had served as interim CFO since August 16, 2026, previously overseeing financial operations and reporting for the biopharmaceutical business.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pfizer Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261103573644) on November 03, 2026, and is solely responsible for the information contained therein.